Apolipoprotein B-containing lipoproteins in atherogenesis

Area of Science:

• Cardiovascular Biology
• Lipid Metabolism
• Atherosclerosis Research

Background:

• Apolipoprotein B (apoB) is essential for lipoprotein structure and atherogenic properties.
• Low-density lipoproteins (LDL), rich in apoB, are a primary cause of atherosclerosis.
• Other apoB-containing lipoproteins possess higher atherogenicity per particle than LDL.

Purpose of the Study:

• To review the role of apoB-containing lipoproteins in atherogenesis.
• To detail mechanisms of atherosclerotic plaque initiation and growth.
• To identify therapeutic targets for reducing atherosclerosis.

Main Methods:

• Review of existing literature on apoB-lipoprotein metabolism and function.
• Analysis of mechanisms of lipoprotein entry, retention, and modification within the artery wall.
• Examination of cellular and immune responses to modified lipoproteins.

Main Results:

• LDL particles enter and are retained in the artery wall, undergoing modifications that promote inflammation.
• Macrophage uptake of modified LDL leads to foam cell formation and necrotic core development.
• Less abundant apoB-lipoproteins contribute significantly to atherogenesis through similar or additional pathogenic pathways.

Conclusions:

• ApoB-containing lipoproteins are central to atherosclerotic plaque development.
• Understanding lipoprotein-driven inflammation and cellular lipid handling is key.
• Interventions targeting plasma lipoprotein levels and vascular responses hold therapeutic promise.